Akebia Therapeutics Inc. sell Global_Player
Start price
23.05.23
/
50%
€1.44
Target price
23.05.24
-
Performance (%)
-21.56%
End price
25.05.23
€1.13
Summary
This prediction ended on 25.05.23 with a price of €1.13. The price of Akebia Therapeutics Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -21.56%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 3.571% | 3.571% | -23.923% |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% |
According to Global_Player what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Sell Akebia Therapeutics Inc.